Sanofi

Sanofi's LixiLan Progresses
Yahoo/Zacks.com
Fri, 01/17/14 - 08:37 am
Sanofi
LixiLan
insulin
Lantus
diabetes
Zealand Pharma
Lyxumia
BIO and Sanofi are pushing FDA to tweak drug shortage rule for vaccines
Fierce Vaccines
Thu, 01/16/14 - 08:16 am
Sanofi
FDA
flu vaccines
vaccines
The J.P. Morgan Healthcare Confab Monday Morning News Dump
TheStreet.com
Mon, 01/13/14 - 10:12 am
JPMHC 2014
GSK
Intercept Pharma
Acorda Therapeutics
Cell Therapeutics
Novartis
Sanofi
Alnylam
Idenix
Alexion
Galena Biopharma
Incyte
Clovis Oncology
Dendreon
Merck
Arena Pharmaceuticals
Sanofi Pays $700 Million for Alnylam Drugs and Stake
Bloomberg
Mon, 01/13/14 - 08:47 am
Sanofi
Alnylam
Patisiran
Johnson & Johnson And Medivation: A Prostate Cancer Marketshare
Seeking Alpha
Tue, 01/7/14 - 12:51 pm
JNJ
Medivation
prostatce cancer
Astellas
Dendreon
Sanofi
Zytiga
Xtandi
Provenge
Sanofi is allowing open access from Jan. 1 on out
Fierce Pharma
Fri, 01/3/14 - 12:02 pm
Sanofi
clinical trial data
Sanofi Will Share Clinical Trial Data, But There Is A Caveat
Forbes
Thu, 01/2/14 - 11:43 am
Sanofi
clinical trial data
Grading Pharma In 2013: 16 Drug Companies Ranked
Forbes
Tue, 12/31/13 - 10:17 am
Bristol-Myers Squibb
Celgene
Gilead Sciences
Biogen Idec
AbbVie
Roche
JNJ
GSK
Amgen
Novo Nordisk
Pfizer
Novartis
Merck
Sanofi
AstraZeneca
Eli Lilly
A Hard Lesson from Sanofi
WSJ Online
Mon, 12/30/13 - 05:48 pm
Sanofi
Genzyme
Lemtrada
FDA
MS
multiple sclerosis
Sanofi MS Drug Lemtrada Fails to Win Backing of U.S. FDA
Bloomberg
Mon, 12/30/13 - 11:16 am
Sanofi
Lemtrada
FDA
MS
multiple sclerosis
Big Pharma Stocks: Year in Review
Yahoo/TheStreet.com
Tue, 12/24/13 - 09:50 am
Big Pharma
drug stocks
Merck
JNJ
GSK
Eli Lilly
Pfizer
Sanofi
Bristol-Myers Squibb
Sanofi faces U.S. class action over MS drug Lemtrada
Reuters
Fri, 12/20/13 - 11:58 am
Sanofi
MS
multiple sclerosis
Lemtrada
Sanofi to tap ACC registry for cardiovascular clinical trial
Yahoo/Reuters
Thu, 12/19/13 - 08:09 am
Sanofi
clinical trials
alirocumab
American College of Cardiology
Sanofi signs on to sell Vivus ED drug in emerging markets
Fierce Pharma
Fri, 12/13/13 - 04:52 pm
Vivus
erectile dysfunction
Sanofi
Stendra
Qsymia
Keep an Eye on AstraZeneca, Avanir, Bristol-Myers Squibb and VIVUS Today
Motley Fool
Thu, 12/12/13 - 11:12 am
AstraZeneca
Avair
Bristol-Myers Squibb
Vivus
metreleptin
Nuedexta
Avanafil
Sanofi
How The Global Pharma Industry Will Shape Up In The Next 5 Years?
Seeking Alpha
Wed, 12/4/13 - 11:38 am
Bristol-Myers Squibb
GSK
JNJ
Ophthotech
Novartis
Regeneron
Roche
Sanofi
Does Sanofi Need to Turn to M&A to Bulk Up Its Oncology Assets?
Motley Fool
Tue, 12/3/13 - 11:35 am
M&A
Sanofi
oncology
Celgene
Clovis Oncology
Seattle Genetics
PSivida: Undervalued Ophthalmology Small-Cap Investment With Upcoming Catalyst
Seeking Alpha
Tue, 12/3/13 - 11:04 am
pSivida
ophthalmology
GSK
Novartis
Pfizer
Regeneron
Roche
Sanofi
Iluvien
Durasert
Medidur
Sanofi Announces New Phase 3 Results for Investigational New Insulin U300
Yahoo
Tue, 12/3/13 - 09:33 am
Sanofi
insulin
diabetes
U300
Sanofi looking at 1-2 billion euros in acquisitions per year - CEO
Reuters
Tue, 11/26/13 - 08:56 am
Sanofi
M&A
Pharma CEOs
Chris Viehbacher

Pages